July 30, 2024 02:53 PM EDTUpdated 06:03 PM
Pharma
FDA+

Ver­tex gets Jan­u­ary de­ci­sion date for non-opi­oid pain med­i­cine

Nicole DeFeudis

Editor

The FDA is ex­pect­ed to make a de­ci­sion on Ver­tex’s non-opi­oid med­i­cine for acute pain by Jan. 30, the com­pa­ny

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Out­look's shares crash as wet AMD drug flunks Phase 3 test

A service from the Financial Times